XML 107 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule I - Condensed Financial information of Parent (Coupang, Inc.) - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities:      
Net cash (used in) provided by operating activities $ (410,578) $ 301,554 $ (311,843)
Investing activities:      
Net cash used in investing activities (675,525) (520,654) (218,224)
Financing activities:      
Repurchase of common units and preferred units 0 (97,043) (114,610)
Deferred offering costs paid (11,618) 0 0
Proceeds from issuance of common stock/units, equity-based compensation plan 62,281 28,613 1,516,378
Repayment of short-term borrowings (166,023) (2,983) (346,349)
Net cash provided by financing activities 3,576,850 178,502 1,184,104
Cash and cash equivalents:      
Net increase in cash and cash equivalents, and restricted cash 2,409,045 29,767 631,625
Cash and cash equivalents, and restricted cash, as of beginning of period 1,401,302 1,371,535 739,910
Cash and cash equivalents, and restricted cash, as of end of period 3,810,347 1,401,302 1,371,535
Parent Company      
Operating activities:      
Net cash (used in) provided by operating activities (57,783) (7,587) 7,429
Investing activities:      
Capital contribution to subsidiaries (1,273,629) (184,490) (2,044,205)
Return of capital contribution from subsidiaries 202,834 253,921 817,977
Net cash used in investing activities (1,070,795) 69,431 (1,226,228)
Financing activities:      
Repurchase of common units and preferred units 0 (97,043) (114,610)
Proceeds from issuance of common units and preferred units, net of issuance costs 3,431,277 28,613 1,516,378
Deferred offering costs paid (11,618) 0 0
Proceeds from issuance of common stock/units, equity-based compensation plan 62,281 0 0
Repayment of short-term borrowings 0 0 (200,000)
Other, net (1,663) 0 0
Net cash provided by financing activities 3,480,277 (68,430) 1,201,768
Cash and cash equivalents:      
Net increase in cash and cash equivalents, and restricted cash 2,351,699 (6,586) (17,031)
Cash and cash equivalents, and restricted cash, as of beginning of period 6,336 12,922 29,953
Cash and cash equivalents, and restricted cash, as of end of period $ 2,358,035 $ 6,336 $ 12,922